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Abstract
Squamous cell carcinomas (SqCC) of the aerodigestive tract have similar etiological risk
factors. Although genetic risk variants for individual cancers have been identified, an agnos-
tic, genome-wide search for shared genetic susceptibility has not been performed. To iden-
tify novel and pleotropic SqCC risk variants, we performed a meta-analysis of GWAS data
on lung SqCC (LuSqCC), oro/pharyngeal SqCC (OSqCC), laryngeal SqCC (LaSqCC) and
esophageal SqCC (ESqCC) cancers, totaling 13,887 cases and 61,961 controls of Euro-
pean ancestry. We identified one novel genome-wide significant (Pmeta<5x10-8) aerodiges-
tive SqCC susceptibility loci in the 2q33.1 region (rs56321285, TMEM273). Additionally,
three previously unknown loci reached suggestive significance (Pmeta<5x10-7): 1q32.1
(rs12133735, near MDM4), 5q31.2 (rs13181561, TMEM173) and 19p13.11 (rs61494113,
ABHD8). Multiple previously identified loci for aerodigestive SqCC also showed evidence of
pleiotropy in at least another SqCC site, these include: 4q23 (ADH1B), 6p21.33 (STK19),
6p21.32 (HLA-DQB1), 9p21.33 (CDKN2B-AS1) and 13q13.1(BRCA2). Gene-based associ-
ation and gene set enrichment identified a set of 48 SqCC-related genes rel to DNA damage
and epigenetic regulation pathways. Our study highlights the importance of cross-cancer
analyses to identify pleiotropic risk loci of histology-related cancers arising at distinct ana-
tomical sites.
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Author summary
Squamous cell carcinomas are specific type of cancer that can arise in multiple organs of
the aerodigestive tract including the lung, oral cavity, oropharynx, larynx and esophagus.
Previous studies have shown that aerodigestive squamous cell carcinomas share common
environmental risk factors (tobacco smoking and alcohol intake). Here, we investigate
genetic factors involved in the risk of aerodigestive squamous cell carcinomas as a group
in a large genetic association study involving 13,887 cancer cases and 61,961 controls. We
identified one genome-wide significant region within 2q33.1 and 3 other suggestive
regions at 1q32.1, 5q31.2 and 19p13.11. Gene-based analyses also identify a list of SqCC-
related genes that are involved in DNA damage response and epigenetic regulation. Our
results suggest some overlap in the genetic factors influencing the risk of aerodigestive
squamous cell carcinomas in European populations and highlights the importance of
cross-cancer studies.
Introduction
The squamous cell carcinomas (SqCC) of the aerodigestive tract [1], lung squamous cell carci-
noma (LuSqCC) and head and neck cancers (HNC,>90% SqCCs) including; oral/pharyngeal
SqCC (OSqCC), larynx SqCC (LaSqCC), and esophageal SqCC (ESqCC); are strongly associ-
ated with common risk factors such as tobacco smoking, alcohol consumption and human
papilloma virus (HPV) infection [2]. Similarly, recent molecular characterization studies
across anatomically distinct SqCCs have shown that histology is more important than tissue of
origin in defining tumor molecular profiles determined by shared features including somatic
mutations, copy number alternations, deregulation of DNA methylation and/or gene expres-
sion[2–4].
Along with behavioral risk factors, it is increasingly recognized that inherited factors also
play a role in aerodigestive SqCC risk. Previous genome-wide association studies (GWAS)
have identified multiple genetic risk variants for individual aerodigestive SqCC types; notably
variants in smoking-related genes at 15q25.1 for LuSqCC [5–7] and 4q23 variants in alcohol-
related genes for upper aerodigestive tract (UADT) cancers [8]. Importantly, candidate-gene
and GWAS studies have previously described rare genetic variants linked to aerodigestive
SqCC risk; including variants near BRCA2 (13q13.1), first identified as a risk factor for ESqCC
in Middle Eastern populations [9] and later described to increase risk of LuSqCC [10] and
UADT SqCC in Europeans [11]. Similarly, at 22q12.1 another rare missense variant within
CHEK2 (rs17879961, p.Ile157Thr) has been linked to reduced risk of lung and UADT SqCCs
[10–13]. Such studies provide evidence of genetic pleiotropy across aerodigestive SqCCs, as
these variants exert cross-cancer effects possibly related to similar underlying mechanisms (i.e.
DNA repair). Furthermore, a recent large-scale genome-wide genetic correlation analysis
across six solid tumors (breast, colorectal, head/neck, lung, ovary and prostate cancer),
highlighted that the strongest genetic correlation was between lung and head and neck cancers
[14].
Collectively aerodigestive SqCC are an important public health issue; not only because as a
group are amongst the most common type of solid tumors [2], but also due to the increasing
global incidence of HPV-related head and neck SqCCs [15]. Identifying genetic risk loci that
can have pleiotropic effects across aerodigestive SqCC sites is important for gaining insight
into shared or divergent molecular basis of different tumors. To further examine pleotropic
risk genomic regions across LuSqCC [16], OSqCC [17], LaSqCC [8] and ESqCC [8] and to
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We performed GWAS meta-analysis on aerodigestive SqCC risk including 13,887 cancer cases
and 61,961 non-overlapping controls of European ancestry. The SqCC cases comprised 7,426
LuSqCC, 5,452 OSqCC, part of the OncoArray Consortium [16–18], and additional 693
LaSqCC and 316 ESqCC previously included in a upper aerodigestive cancer GWAS [8]
(Table 1). Summary associations statistics were used to perform fixed-effects (F-E) and a sub-
set-based meta-analyses using the ASSET software [19]. This approach allows exploration of
all possible subsets of studies to identify the strongest association signal, while accounting for
subset search multiple testing, and adjusting standard errors to account for overlapping con-
trols between analyses; partial overlap (N = 2,500) between LuSqCC and OSqCC and complete
overlap between the ESqCC and LaSqCC. After quality control steps, 8,468, 885 genetic vari-
ants with summary statistics in at least three of the four interrogated SqCC types were used for
analyses. The quantile–quantile plot (F-E meta-analysis, S1 Fig) shows little evidence of geno-
mic inflation after correcting for sample size (λ = 1.006). Loci that reached Pmeta < 5x10-7 were
considered noteworthy; meta-analysis results for all SNPs below P<5x10-5 are shown in S1
Table. From noteworthy loci, those not previously reported in the lung [16] or oral/pharyngeal
[17] analyses (single-cancer P> 5x10-7) were considered as novel SqCC regions. We identified
one novel aerodigestive SqCC loci at genome-wide significance (F-E meta-analysis, Pmeta <
5x10-8) within 2q33.1. We detected suggestive associations with SqCC risk at 1q32.1, 5q31.2
and 19p13.11, not detected in previous analyses (Fig 1 and Table 2). Other loci that reached
Pmeta <5x10-7 were considered pleiotropic if these had at least two cancer sites at P<5x10-4
and the same effect direction in all tumor sites. Using these criteria, the loci categorized as
pleiotropic (4q23, 6p21.32, 6p21.33, 6p22, 9p21.3 and 13q13.1) included 108 SNPs (S2 Table),
the lead SNP (lowest Pmeta) for each of these regions is shown in Table 3. In contrast, other
known cancer regions that reached the GWAS threshold (12p13.33, 15q25, 19q13.2) or Pmeta
< 5x10-7 (4p14, 9q34.1, 10q24.31, 11q21, 15q15.3) in the SqCC meta-analysis were not pleio-
tropic (Fig 1). We did not observe additional associations reaching the GWAS threshold or
suggestive significance in the ASSET subset-based meta-analysis, indicating that at least for the
strongest associations, the effects have consistent direction across the examined aerodigestive
SqCC types. For noteworthy SNPs, we performed expression quantitative trait (eQTL) analyses
with normal lung tissues from the multicenter Lung Microarray Study (S3 Table). We also
query these variants in multiple public genomic annotation databases. The Genotype-Tissue
Expression (GTEx) for lung and esophageal eQTLs (S4 Table). ROADMAP and the Encyclo-
pedia of DNA Elements (ENCODE) for epi/genomic annotations (S5 Table). The NHGRI-EBI
GWAS Catalog (S6 Table) for disease/phenotype associations and the COSMIC catalogue for
cancer somatic mutation information (S7 Table). Lastly, we performed a genome-wide gene-
based association analysis (GWGAS) of the SqCC meta-analyses results using MAGMA
(Multi-marker Analysis of GenoMic Annotation)[20] (S8 Table). To map individual SNPs to
genes we used the Functional Mapping and Annotation (FUMA, S9 Table) [21]. Overlapping
genes from these were used to assemble a list of aerodigestive SqCC genes (S10 Table) used in
enrichment analyses (S11 Table).
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Novel loci with pleiotropic aerodigestive SqCC associations
At 2q33.1, the intronic variant rs56321285[A] within the transmembrane protein 237
(TMEM237) gene was associated with reduced risk of aerodigestive SqCC (OR = 0.90, Pmeta =
6.99x10-9). This association showed little heterogeneity across cancer sites LuSqCC: OR = 0.92,
P = 2.51x10-4; OSqCC: OR = 0.89, P = 2.34x10-4; LaSqCC: OR = 0.79, P = 3.83x10-3; ESqCC:
OR = 0.80, P = 3.56x10-2 (Fig 2A). rs56321285 is in low linkage disequilibrium (LD) with other
variants in the region (S2 Fig) including rs10931936 (r2 = 0.02, 1000 Genomes (1KG), Europe-
ans), the lead SNP of a weaker 2q33.1 association (SqCC ORmeta = 1.08, Pmeta = 1.83x10-6).
Table 1. Summary of studies included in the aerodigestive SqCC meta-analysis.
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Larynx 693 2,847 Illumina
Human-
Hap300
HRC R2>0.3 8,840,446 Age, sex,
PCs
European McKay et al
2011
Esophageal 316 2,847
R2 = imputation quality measure; MAF = minor allele frequency; UADT = upper aerodigestive tract; HRC = Haplotype Reference Consortium panel;
a Overlapping controls N = 2,500 (lung and oral/oropharynx) and N = 2847 (larynx and esophageal).
b Cases with overlapping oral and oropharyngeal tumors.
https://doi.org/10.1371/journal.pgen.1009254.t001
Fig 1. Manhattan plot of aerodigestive SqCC genome-wide association fixed-effects meta-analysis results. The y-axis corresponds to −log10 P-values,
and x-axis to genomic positions. Horizontal red dashed line (P = 5x10−8) and black dashed line (P = 5x10−7). Highlighted in red are the newly identified
pleotropic aerodigestive SqCC loci (P<5x10-8), in blue new loci at P<5x10-7 and in purple previously identified pleotropic loci (at least 2 cancer sites). Loci
labeled in black are loci that reached P<5x10-7 but were not pleiotropic associated only in single-cancer analyses.
https://doi.org/10.1371/journal.pgen.1009254.g001
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rs10931936 is in LD with nearby CASP8-ALS2CR12 variants which have been previously
linked with risk of multiple cancers in Europeans [22], as well as esophageal and lung cancer
in Chinese populations [23,24]. CASP8 plays an important role in apoptosis; mutations in this
gene have been described in 2% of LuSqCC and 6% of UADT SqCC tumors (S7 Table) [25].
However, the 2q33.1 genome-wide significant SNP (rs56321285) associated with aerodigestive
SqCC risk, seems independent from CASP8-ALS2CR12 variants. In eQTL analyses using lung
tissues Lung Microarray Study (S3 Table), rs56321285 is a nominally significant cis-eQTL for
AOX2P (Laval and Groningen datasets) and CDK15 (Laval and UBC datasets). However,
rs56321285 is not a lung or esophageal eQTL in the GTEx catalog [26]. Regulatory annotations
from ENCODE [27] and ROADMAP [28] are consistent with rs56321285 mapping to a
H3K4me1 enhancer in lung fibroblasts (S5 Table).
The lead SNP (rs12133735) at 1q32.1; the G allele was associated with increased risk of aero-
digestive SqCC (ORmeta = 1.08, Pmeta = 2.16x10-7, Table 2 and Fig 2B), predominantly driven
by the LuSqCC (OR = 1.07, P = 4.63x10-4) and OSqCC (OR = 1.14, P = 9.82x10-6) results.
rs12133735 is located 3’ of MDM4 (S3 Fig) and is a MDM4 eQTL in all datasets from the lung
eQTL study (S3 Table and S4 Fig), and in lung and esophageal GTEx tissues [26] (S4 Table).
MDM4 is a crucial negative regulator of p53 and its upregulation has been described as a com-
mon p53 inactivation mechanism in tumors [29,30]. In contrast, in our analyses rs12133735-G
is associated with lower MDM4 expression in lung tissues and increased SqCC risk. However,
the regulation of MDM4 expression and interaction with p53 involves complex mechanisms
(including alternative splicing) and are reported to differ between normal and cancer tissues
[29]. In Europeans, rs12133735[G] is in moderate LD (r2 = 0.61, 1KG) with rs4245739 [C]
(SqCC OR meta = 1.07, P = 7.62x10-6) which has been associated with increased risk of triple
Table 2. Novel genomic regions with pleiotropic aerodigestive SqCC associations.
Regiona EA/OAb Gene EAF SqCC site OR 95%CI P ORmeta 95%CImeta Pmeta c
Genome-wide significant loci
2q33.1 A/G TMEM237 0.31 Lung 0.92 0.88–0.96 2.51E-04 0.902 0.87–0.94 6.99E-09
rs56321285 Oral/oropharynx 0.89 0.83–0.94 2.34E-04
2:202505545 Larynx 0.79 0.67–0.93 3.83E-03
Esophagus 0.8 0.64–0.98 3.56E-02
Suggestive loci
1q32.1 G/T MDM4 0.35 Lung 1.07 1.03–1.11 4.63E-04 1.08 1.05–1.12 2.16E-07
rs12133735 Oral/oropharynx 1.14 1.08–1.21 9.82E-06
1:204556836 Larynx 1.05 0.92–1.20 5.14E-01
Esophagus 1 0.83–1.19 9.74E-01
5q31.2 G/A TMEM173 0.28 Lung 1.09 1.05–1.14 5.29E-05 1.09 1.05–1.13 1.74E-07
rs13181561 Oral/oropharynx 1.1 1.04–1.17 1.74E-03
5:138850905 Larynx 1.12 0.96–1.3 1.44E-01
Esophagus 1.06 0.87–1.3 5.62E-01
19p13.11 A/G ABHD8 0.3 Lung 1.09 1.05–1.14 2.05E-05 1.09 1.05–1.12 9.86E-08
rs61494113 Oral/oropharynx 1.09 1.03–1.16 4.91E-03
19:17401859 Larynx 1.15 1.00–1.31 5.22E-02
Esophagus 1.05 0.87–1.27 5.90E-01
a Lead SNP (lowest P, F-E meta-analysis), regions at P<5x10-7
b EA = Effect allele/OA = other allele; EAF = average effect allele frequency between sites.
c F-E meta-analysis (ASSET) accounting for control overlap between Lung SCC and oral/pharynx analysis and larynx and esophageal analysis.
https://doi.org/10.1371/journal.pgen.1009254.t002
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Table 3. Variants within known genomic loci with pleiotropic aerodigestive SqCC associations.
Regiona EA/RAb Gene EAF SqCC site OR 95%CI P ORmeta 95%CImeta Pmeta
c
4q23 T/C ADH1B 0.05 Lung 0.92 0.84–1.01 7.35E-02 0.80 0.74–0.86 1.89E-09
rs1229984 Oral/oropharynx 0.58 0.50–0.67 8.32E-13
4:100239319 Larynx 0.67 0.49–0.92 1.42E-02
Esophagus 0.28 0.15–0.53 9.28E-05
6p21.33 G/A STK19 0.09 Lung 1.29 1.22–1.37 1.41E-16 1.26 1.19–1.32 2.42E-19
rs389884 Oral/oropharynx 1.21 1.09–1.35 4.41E-04
6:31940897 Larynx 1.21 0.95–1.52 1.19E-01
Esophagus 1.24 0.92–1.68 1.65E-01
6p21.32 G/A HLA-DQA1 0.41 Lung 1.17 1.12–1.21 3.01E-14 1.16 1.12–1.19 4.82E-19
rs9271611 Oral/oropharynx 1.15 1.08–1.22 1.23E-05
6:32591609 Larynx 1.27 1.07–1.49 5.14E-03
Esophagus 1.02 0.82–1.28 8.36E-01
9p21.3 T/C CDKN2B-AS1 0.30 Lung 1.09 1.05–1.14 1.34E-05 1.11 1.07–1.14 5.55E-10
rs7857345 Oral/oropharynx 1.14 1.07–1.21 3.73E-05
9:22087473 Larynx 1.18 1.03–1.36 1.91E-02
Esophagus 1.07 0.89–1.29 4.63E-01
13q13.1 A/G BRCA2 0.01 Lung 2.12 1.77–2.55 1.10E-15 2 1.73–2.32 2.30E-21
rs11571815 Oral/oropharynx 1.67 1.28–2.18 1.67E-04
13:32968550 Larynx 3.04 1.41–6.57 4.53E-03
Esophagus 4.73 2.14–10.5 1.24E-04
a Lead SNP (lowest P, F-E meta-analysis), regions at P<5x10-7;
bEA = Effect allele/OA = other allele; EAF = average allele frequency between sites;
c F-E meta-analysis (ASSET) accounting for control overlap.
https://doi.org/10.1371/journal.pgen.1009254.t003
Fig 2. Forest plots of ORs for new aerodigestive SqCC-related loci. a) rs56321285 at 2q33.1 (TMEM23). Subset refers to subset based meta-analyses
(ASSET). b) rs12133735 at 1q32.1 (near MDM4).
https://doi.org/10.1371/journal.pgen.1009254.g002
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negative breast cancer [31,32] and ovarian cancer [33] (S6 Table). Intriguingly, rs4245739 [C]
has also been associated with reduced prostate cancer risk (Europeans) [34] and lower risk of
all cancers in Asians [35,36]. A candidate-gene study [37] also described associations between
risk of HPV16-associated OSqCC and 1q32.1 MDM4 SNPs including rs11801299 (r2 = 0.12,
with rs12133735, 1KG, Europeans), which was marginally associated with SqCC risk in our
analysis (ORmeta = 0.91, Pmeta = 1.34x10-5).
The lead variant at 5q31.2 rs13181561[G] (ORmeta = 1.09, P meta = 1.74x10-7, Fig 3A) near
TMEM173 (S5 Fig) showed homogenous associations across tumor sites but only significant
in LuSqCC and OSqCC. rs13181561 is associated with DNAJC18 and SPATA24 gene expres-
sion in lung tissues (Laval, Groningen and UBC; S3 Table), and of DNAJC18 in esophagus
(GTEx, S4 Table). rs13181561 overlaps with an enhancer in esophageal and lung tissues (S5
Table). Additionally, rs13181561[G] is highly correlated with rs7447927[C] (r2 = 0.94, 1KG,
Europeans), the latter (ORmeta = 1.08, P = 5.45x10-7) has been previously linked to increased
ESqCC risk in Chinese populations[38] (S6 Table).
Another suggestive SqCC association was detected at rs61494113[A] within 19p13.11;
(ORmeta = 1.09, Pmeta = 9.9x10-8); showed similar odds ratios across SqCCs sites albeit with
limited power for larynx and esophageal SqCCs (Table 1 and Fig 3B). Lung eQTL analysis
showed rs61494113 as a significant eQTL for OCEL1 (Laval and Groening, S3 Table). How-
ever, the GTEx catalog shows rs61494113 as an esophageal ABHD8 eQTL and a BABAM1
splice-QTL (lung and esophagus) but not for OCEL1 (S4 Table). rs61494113 maps within
H3K4me1 histone and DNase marks in normal lung tissues and in lung carcinoma cells (S5
Table). rs61494113[A] is in complete LD with rs56069439[A] (r2 = 1, 1KG, Europeans), also
associated with a SqCC risk (S1 Table and S6 Fig) and previously linked with increased risk of
ER-negative breast [39] and ovarian [39,40] cancers (S6 Table). The 19p13.11 region of LD
contains multiple genes involved in DNA damage repair including BABAM1 a BRCA1-inter-
acting protein[41] and ANKLE1 [42].
Known risk loci with pleiotropic aerodigestive SqCC associations
Chromosome 6 showed a large aerodigestive SqCC association signal overlapping the human
leukocyte antigen (HLA), region previously identified in the LuSqCC[16] and oral/pharyngeal
SqCC[17] cancer analyses. rs389884 near STK19 was the top pleotropic SNP at 6p21.33 (SqCC
ORmeta = 1.26; P = 2.4x10-19, Table 3 and S2 Table). 6p21.33 SNPs are in moderate LD
(rs389884 and rs115785414, r2>0.4, 1KG, Europeans) with variants at 6p22.1, suggesting a
common haplotype. We also detected associations at 6p21.32; rs9271611 near HLA-DQA1
(class II) is not correlated (S7 Fig) with 6p21.33 SNPs, pairwise LD between rs9267123 and
rs9271611 r2 = 0.09 (1 KG, Europeans). This second association reduced aerodigestive SqCC
risk (ORmeta = 0.85; P = 1x10-17) mainly for OSqCC and LuSqCC (Table 3). These observations
are in concert with our previous findings [17,43]; of at least two haplotypes within the HLA
region with different effects on cancer risk. Genetic variants at 9p21.33 have also been associ-
ated with multiple malignancies including lung adenocarcinoma [16] and OSqCC [17].
rs7857345 (9p21.33 lead SNP mapped to CDKN2B-AS1, S8 Fig) was associated with a slight
increase in SqCC risk (ORmeta = 1.11, Pmeta = 5.55x10-10, Table 3). rs7857345 is in LD with
rs61271866 (r2 = 0.51) previously associated with ESqCC in Chinese populations [38]. How-
ever, rs7857345 is not in LD with rs885518 (r2 = 0.006, 1KG, Europeans), suggesting that this is
a different signal to that previously reported for lung adenocarcinoma risk in Europeans[16].
Expectedly, two other previously reported rare variants at 4q23 (rs1229984, ADH1B) and
13q13.1 (rs11571815, BRCA2) also displayed pleiotropy in this analyses [10–12] [44] (Fig 1,
Table 3). Of note, we did not observe pleiotropy for variants at 15q25.1, a known locus related
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to lung cancer[5] and smoking behavior [45]. The lead SNP in this region rs55781567
(CHRNA5) was prominent for SqCC (ORmeta = 1.19; Pmeta = 1.74x10-29), but this result was
primarily driven by the LuSqCC (OR = 1.3; P = 4.6x10-41) with no effect in any other SqCC
site (OSqCC P = 0.26; LaSqCC P = 0.68 and ESqCC P = 0.7, S1 Table and S9 Fig). Variants at
15q25 have been interrogated before in relation to upper aerodigestive cancer risk (including
samples used in this study) [46]; significant associations were found only in women and unre-
lated to smoking behavior suggesting that 15q25.1 SNPs relate differently to LuSqCC com-
pared to oral/oropharyngeal SqCCs. Importantly, none of the published HNC GWAS in
Chinese or Europeans have reported associations with 15q25 variants. Thus, while the relation
between this locus with smoking behavior and lung cancer is unequivocal; to date there is no
evidence of a clear link between 15q25 and head and neck cancer. Future studies including
more cases and stratified analyses should examine this further.
Aerodigestive SqCCs risk genes and pathways
To gain further functional insight into aerodigestive SqCC genetic susceptibility, we used the
results of the F-E meta-analyses to map risk variants to genes (FUMA) and to perform a
genome-wide gene-based association analysis (GWGAS) using MAGMA. The SNP to gene
analyses highlighted 182 genes within 21 genomic regions (S8 Table) and the gene-based analy-
sis identified 51 significant genes related to aerodigestive SqCC (Bonferroni correction
P<2.67x10-6, S9 Table). Next, we overlapped the results from the two analyses and obtained a
list of 48 SqCC-related genes (S10 Table), which includes TMEM237 (2q33.1), MDM4 (1q32.1),
AC138517.1 (5q31.2) and BABAM1 (19p13.11) located within the pleotropic SqCC risk regions
identified in the meta-analyses. Expectedly, the HLA region in chromosome 6 had the highest
number of genes mapped (24), however and interestingly the most prominent signals were
located within 6p22 and included>10 histone genes. Gene-set enrichment analyses using
Fig 3. Forest plots of ORs for new aerodigestive SqCC-related loci. a) rs13181561 at 5q31.2 (TMEM173); b) rs61494113 at 19p13.1 (ABHD8). Subset
refers to subset based meta-analyses (ASSET).
https://doi.org/10.1371/journal.pgen.1009254.g003
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these SqCC-related genes and canonical pathways resulted in 63 significant gene sets (S11
Table) most of which mapped to DNA damage pathways (telomere, checkpoint, oxidative
stress and strand break response) as well as epigenetic regulation pathways related to histones
and DNA methylation.
Discussion
This study identified one novel genome-wide significant loci associated with aerodigestive
SqCC risk (2q33.1). Four other loci (1q32.1, 5q31.2 and 19p13.11) showed suggestive associa-
tions with SqCC. Amongst known SqCC loci, four showed evidence of pleiotropy across can-
cer sites. Our results demonstrate the power of cross-cancer analyses of histologically-related
tumors to identify genetic risk loci.
It is notable that many of the detected associations are plausibly related to cancer risk. Our
results from 2q33.1 and 5q31.2 combined with previous evidence [23,24,38] indicate that these
loci relate to SqCC risk across distinct ancestries (Asians and Europeans). Moreover, the signal
at 2q33.1 was also proximal to CASP8-ALS2CR12, a region previously associated with other
cancers [47,48]. Likewise, the 1q32.1 and 19p13.11 genomic regions implicate genes like
MDM4 and BABAM1, which have been previously associated with risk of other epithelial
malignancies including breast, prostate and ovary [31,36,39,49]. Lastly, these observations not
only make our findings more plausible but also expand our understanding of cross-cancer
genetic susceptibility and complex biology behind these associations.
The top associations displayed homogenous effect direction across SqCC sites and stronger
associations in the F-E meta-analyses compared to the subset-based meta-analyses. This could
relate to the shared histology and risk factors of aerodigestive SqCCs. Nonetheless, we cannot
rule out heterogeneous SqCC associations that we were not able to detect in our data. How-
ever, and not surprisingly, for these loci effect sizes were small (range of ORmeta 0.89–1.09)
which limited association detection in the smaller single cancer-analysis using commonly
applied GWAS P-values thresholds. In contrast, most of the known loci that exhibited pleiot-
ropy in our analysis have larger effects sizes, particularly true for the less common variants
within BRCA2 and CHEK2.
Our study has several major strengths. Firstly, we leveraged available European GWAS data
sets to perform a large-scale meta-analysis of aerodigestive SqCC risk. Secondly, we analyzed
tissue-specific gene expression data from multiple studies and integrated these data with pub-
licly available information on epigenetic regulatory profiles of relevant tissues to aerodigestive
SqCCs. Thirdly, for the newly discovered loci we also integrated our results with existent data
from genetic susceptibility studies in other populations as well as available tumor repository
information. However, this study has a number of limitations. The sample sizes for laryngeal
and esophageal SqCC were very limited; this impacted our power to identify more signals at
the GWAS threshold. The described associations (particularly those at P> 5x10-8) could be
spurious due to the high testing burden and lack of replication; other studies should examine
these regions further to replicate these results. Our criteria to identify pleiotropic loci tried to
capture robust loci across multiple aerodigestive SqCC while accommodating for the sample
size imbalances across tumor sites. We recognize that this approach did not fully account for
multiple testing and could have missed some pleiotropic regions. Pleiotropic studies are lim-
ited by sample size of existent GWAS data, as well as the frequency of variants in these regions.
Future studies should investigate this further using lager samples, different methodology, and
if possible, including SqCCs from other sites (e.g. cervical, anal and bladder). Also, our analy-
ses were restricted to individuals of European ancestry, performing a similar analysis including
other genetic backgrounds offers the potential to pinpoint loci that exert effects across
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ethnicities. In summary, we provide evidence for one new locus (2q33.1) influencing aerodi-
gestive SqCC risk, and highlight loci for future investigation. Future work should investigate
the biological mechanisms underscoring these associations to unearth shared and divergent
molecular features of these histologically similar tumors.
Methods
Ethics statement
Informed written consent was obtained from all participants, and all contributing studies have
been approved by the IARC Institutional Review Board (IRB; references: 14–03, 13–17, 07–02)
which requires to obtain local ethics committees approvals prior to their enrolment and
evaluation.
Study population
This meta-analysis includes data from three previous studies of lung squamous cell[16], oral/
pharyngeal[17] and upper aerodigestive tract (UADT) cancers[8], totaling 13,887 cases and
61,961 non-overlapping controls. The characteristics and references for each study are sum-
marized in Table 1. The SqCC cases comprise 7,426 LuSqCC, 5,452 OSqCC, part of the
OncoArray Consortium (http://epi.grants.cancer.gov/oncoarray/) [16,17], and additional 693
LaSqCC and 316 ESqCC previously included in a upper aerodigestive cancer GWAS[8]. Con-
trols partially overlapped (N = 2,500) between the LuSqCC and OSqCC analyses, and
completely overlap (N = 2,847) between the ESqCC and LaSqCC analyses. For this analysis,
GWAS summary-statistics for single-site SqCCs were derived using only individuals of Euro-
pean ancestry across multiple epidemiological studies from Europe, North and South
America.
Genotyping and imputation
For each of the studies, genomic DNA samples were previously isolated from blood or buccal
cells. Genotyping for the lung and oral/pharyngeal cancers OncoArray Consortium[18] stud-
ies, was performed at the Center for Inherited Disease Research (CIDR) using the Illumina
OncoArray custom designed for cancer studies. Genotype calls were made in GenomeStudio
software (Illumina) using a standardized cluster file for OncoArray studies. The esophageal
and larynx cancer cases and controls from the upper aerodigestive tract GWA study[8] were
genotyped using the Illumina Sentrix HumanHap300 BeadChip at the Centre d’Etude du Poly-
morphisme Humain (CEPH) and the Centre National Genotypage (CNG Evry France) as pre-
viously described[8]. Genotype data have been deposited dbGaP (https://www.ncbi.nlm.nih.
gov/gap/) accession number phs001202.v1.p1 for the oral and pharyngeal study[17] and for
the lung data[16] accession numbers phs001273.v3.p2 and phs000876.v2.p1. The lung cancer
GWA study[16] was imputed using the 1000 genomes reference panel (phase3) (http://
phase3browser.1000genomes.org/index.html/) and the oral/pharyngeal cancer, larynx and
esophageal cancer GWAS were imputed using the Haplotype Reference Consortium Panel[50]
(http://www.haplotype-reference-consortium.org/) using the University of Michigan Imputa-
tion Server [51] (https://imputationserver.sph.umich.edu/). Only variants with imputation
quality of R2> 0.3 were used in the meta-analysis.
Summary association statistics and meta-analyses
Cancer risk association results from two previous OncoArray Consortia studies (LuSqCC[16]
and OSqCC[17]) and the esophageal and laryngeal analyses ORs, P-values and standard errors
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for each SNP for each cancer site were obtained using logistic regression with a log additive
models adjusted for age, sex and principal components using plink2[52] (https://www.cog-
genomics.org/plink2/) and R[53] (http://www.r-project.org/). Summary statistics for the lung
SqCC data are deposited in dbGaP (phs001273.v3.p2). The oral and pharyngeal GWAS sum-
mary statistics by cancer site and world region have been deposited in the IEU Open GWAS
platform (https://gwas.mrcieu.ac.uk/) under the GWAs IDs: ieu-b-89, ieu-b-90, ieu-b-94, ieu-
b-96, ieu-b-93, ieu-b-97, ieu-b-91, ieu-b-95 and 98. Meta-analyses were performed using a
fixed-effects (F-E) and subset-based meta-analysis using the ASSET software tool [19] (https://
dceg.cancer.gov/tools/analysis/asset/). ASSET allows exploration of all possible subsets of stud-
ies to identify the strongest association signal, while accounting for subset search multiple test-
ing, and adjust standard errors to account for overlapping controls between analyses; partial
overlap (N = 2,500) between the LuSqCC and OSqCC and complete overlap between the
ESqCC and LaSqCC analyses. Meta-analysis for a SNP was performed when at least three can-
cer sites had association results. P-values from both analyses were two-sided. Meta-analyses
results for fixed-effects and subset-based were considered noteworthy if these reach P<5x10-7.
Loci were considered as new if these had not been previously reported in the single SqCC can-
cers analysis (P>5x10-7 for any single site). Loci with previously reported LuSqCC or OSqCC
were characterized a pleiotropic if: 1) Pmeta<5x10-7; 2) two single cancer association results at
P<5x10-4 and consistent effect direction across all cancer sites. All analyses were performed
using the R statistical environment version 3.4.3[53]. Linkage disequilibrium (LD) calculations
(R2) were performed using the LDlink[54] tool and the 1000 Genomes Project European
ancestry populations. Regional association plots were generated using stand-alone LocusZoom
v1.4[55] (https://github.com/statgen/locuszoom-standalone/).). Forest plots of association
results were produce using the metafor R package[56].
Lung and esophageal cis-eQTLs
To investigate the association between lead SCC variants and mRNA expression, we used
three lung eQTL data sets from the Microarray eQTL study. In the Microarray eQTL study
[57], lung tissues for eQTL analysis were obtained from patients who underwent lung surgery
at three academic sites: Laval University, the University of British Columbia (UBC) and the
University of Groningen. Whole-genome gene expression profiling in the lung was performed
on a custom Affymetrix array and is available through GEO (https://www.ncbi.nlm.nih.gov/
geo/) accession number GSE23546. Genotyping was carried out on the Illumina Human
1M-Duo BeadChip array, data is accessible in dbGaP (phs001745.v1.p1). Genotypes and gene
expression levels were available for 408 (Laval University), 342 (Groningen) and 287 (UBC)
patients. Microarray and genotypes preprocessing, quality control and eQTL mapping have
been described previously[58]. We also investigated top aerodigestive SqCC associations in the
public GTEx catalog (V8)[26] for lung and esophageal tissue eQTLs and sQTLs, summary sta-
tistics based on RNAseq and genotypes analyses obtained via the GTEx data portal (https://
www.gtexportal.org).
Functional genomic annotation and gene-based analyses
To functionally annotate newly identified aerodigestive SqCC regions, we leveraged multiple
resources: the Encyclopedia of DNA Elements (ENCODE)[27] (https://www.encodeproject.
org/) and ROADMAP Epigenomics[28] (http://www.roadmapepigenomics.org/) catalogs to
obtain epi/genomic regulatory annotations (chromatin states, histones, enhancers, promoters
and transcription binding sites) for lung and esophageal tissues and cell-types obtained
through HaploReg 4.1 using the HaploR R package[59]); the NHGRI-EBI GWAS Catalog
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(v1.0 e98, https://www.ebi.ac.uk/gwas/) [60] for previously reported disease/phenotype associ-
ations and the COSMIC catalogue (v90, https://cancer.sanger.ac.uk/cosmic) for cancer
somatic mutation information. To provide additional insight into functional and biological
mechanisms underlying aerodigestive SqCC genetic susceptibility, we performed a genome-
wide gene-based association analysis (GWGAS) of the SqCC meta-analyses results using
MAGMA (Multi-marker Analysis of GenoMic Annotation)[20]. We also used the Functional
Mapping and Annotation (FUMA, https://fuma.ctglab.nl/)[21] which maps individually sig-
nificant SNPs to genes. We selected overlapping genes from the MAGMA (Bonferroni-cor-
rected P-value <2.7x10-6) and FUMA results were used to assemble a list of genes implicated
in aerodigestive SqCC genetic risk. This gene list was used to perform a gene-set analysis for
curated canonical biological pathways (containing between 10 and 500 genes) from MSigDB
collections[61]; including GO[62], KEGG[63], REACTOME[64] and BIOCARTA[61]. Path-
way analyses were performed using MAGMA default settings of 10,000 permutations and
applied a Bonferroni correction.
Supporting information
S1 Fig. SqCC F-E meta-analyses. Quantile-quantile plot of the p-values for ASSET F-E meta-
analyses results including lung, oral/oropharyngeal, larynx and esophageal SqCCs. (corrected
λ = 1.006).
(TIFF)
S2 Fig. Regional association plot at 2q33.1. Chromosome positions (x-axis) and -log10 P-
value (y-axis) SqCC meta-analysis at 2q33.1. Genetic variants colored red according to their
LD with rs56321285 (2q33.1 lead SNP) and colored in blue according to LD values with second
lead SNP rs1830298. rs563321285 and rs1830298 r2 = 0.02.
(TIF)
S3 Fig. Regional association plot at 1q32.1. Chromosome positions (x-axis) and -log10 P-
value (y-axis) of SqCC F-E meta-analysis at 1q32.1. Genetic variants are colored according to
their LD with the rs12133735 (red) and with rs4245739 (blue) a variant previously associated
with cancer risk; rs12133735 and rs4245739 (r2 = 0.63).
(TIF)
S4 Fig. rs12133735 MDM4 lung eQTL. Boxplots for rs12133735 and MDM4 gene expression
in 3 datasets from the Microarray eQTL study, from left to right: Laval University, University
of British Columbia (UBC) and 3. University of Groningen.
(TIF)
S5 Fig. Regional association plot at 5q31.2. Chromosome positions (x-axis) and -log10 P-
value (y-axis) SqCC F-E meta-analysis at 5q31.2. Genetic variants colored according to their
LD with the labeled SNP (purple diamond). rs13181561 and rs7447927 (r2 = 0.94).
(TIF)
S6 Fig. Regional association plot at 19p13.11. Chromosome positions (x-axis) and -log10 P-
value (y-axis) SqCC F-E meta-analysis at 19p13.11. Genotyped and imputed variants colored
according to their LD with the labeled SNP (purple diamond). rs61494113 and rs56069439 r2
= 1.
(TIF)
S7 Fig. Regional association plot at 6p22.1- 6p21.33. Chromosome positions (x-axis) and
-log10 P-value (y-axis) SqCC F-E meta-analysis at 6p22.1- 6p21.33. Variants colored according
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to their LD with SNP rs9267123 (lead variant at 6p21.33). rs3116813 (6p22.1) is in moderate
LD with rs9267123 (r2 = 0.5). rs1049213 at 6p21.33 is not correlated with rs9267123 (r2 =
0.01).
(TIF)
S8 Fig. Regional association plot at 9p21.3. Chromosome positions (x-axis) and -log10 P-
value (y-axis) SqCC meta-analysis at 9p21.3. Variants colored according to their LD with SNP
rs7857345 (9p21.3 lead variant).
(TIF)
S9 Fig. Regional association plot at 15p25.1. Regional association plot at 15q25 Chromosome
positions (x-axis) and -log10 P-value (y-axis). A. aerodigestive SqCC P-values; B. Lung SqCC
P-values; C. Oral and oropharyngeal cancer SqCC P-values. Genetic variants colored red
according to their LD with rs55781567 (lowest P-value at 15q5 in the meta-analysis).
(TIF)
S1 Table. Results with P<5x10-5 aerodigestive SqCC meta-analyses. All variants with
P<5x10-5 in the fixed-effects (F-E) ASSET meta-analyses of aerodigestive SqCC. Results for
each SqCC site are also shown.
(XLSX)
S2 Table. Pleiotropic aerodigestive SqCC risk variants. 108 variants with Pmeta<5x10-7; in
the fixed-effects (F-E) meta-analyses; two single-cancer analyses at P<5x10-4 and consistent
effect direction across cancer sites.
(CSV)
S3 Table. Lung Cis-eQTLs for aerodigestive SqCC loci. Cis-eQTLs for novel SqCC loci in
the lung Microarray eQTL study datasets.
(XLSX)
S4 Table. Cis-eQTLs and cis-sQTLs for new SqCC loci. Lung and esophageal Cis-eQTLs and
cis-sQTLs in the GTEx catalog V8 for new SqCC loci.
(XLSX)
S5 Table. Chromatin states and histone marks in lung and esophageal tissues or cells for
new SqCC loci. Chromatin and histone annotations for new SqCC loci from the Roadmap
and ENCODE projects.
(XLSX)
S6 Table. Summary of reported cancer risk associations within the newly SqCC risk loci.
NHGRI-EBI Catalog (v1.0 e98 2020-02-08) reported cancer risk associations for lead SNP (or
proxies r2>0.6) within the new SqCC loci.
(XLSX)
S7 Table. Aerodigestive loci genes with somatic mutations. Genes within SqCC new loci
with somatic mutations in the COSMIC catalogue. (release v90, 5th September 2019).
(XLSX)
S8 Table. Significant results from the gene-based aerodigestive SqCC associations. Analy-
ses performed with MAGMA with 18669 protein-coding genes.
(XLSX)
S9 Table. Aerodigestive SqCC results from the FUMA SNPs to genes mapping.
(XLSX)
PLOS GENETICS Genome-wide association meta-analysis of aerodigestive squamous cell cancers
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1009254 March 5, 2021 14 / 19
S10 Table. Genes overlapping between FUMA and MAGMA analyses.
(XLSX)
S11 Table. Aerodigestive SqCC results from gene set enrichment analyses.
(XLSX)
Acknowledgments
We acknowledge all the participants involved in this research and the funders and support.
The authors would like to thank the staff at the Respiratory Health Network Tissue Bank of
the FRQS for their valuable assistance with the lung eQTL data set at Laval University. The
lung eQTL study at Laval University was supported by the Fondation de l’Institut Universitaire
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